EPIXIENNE
Live / Registered — Registered (as of 13 May 2025)
What this means for you
Registered since 13 May 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97545961
- Registration number
- 7789944
- Mark type
- Stylized text
- Filed
- 12 Aug 2022
- Published for opposition
- 25 Mar 2025
- Registered
- 13 May 2025
- Attorney of record
- Phillip Barengolts
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for humans for treatment of gynecological pain diseases and inflammatory diseases, disorders, and deficiencies; pharmaceutical preparations for humans for treatment of cardiological pain and inflammatory diseases, disorders, and deficiencies; pharmaceutical preparations for treatment of cystic, pain, and inflammatory diseases of the kidney; pharmaceutical preparations for humans for treatment of pain and inflammation caused by hormone related disorders, cancer, or genetic deficiencies; none of the foregoing including hygiene products or preparations for treating skin disorders
Owner
- Bayer Aktiengesellschaft, Leverkusen, DE
- Bayer Aktiengesellschaft, Leverkusen, DE
- Bayer Aktiengesellschaft, Leverkusen, DE
Prosecution history
- 13 May 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 May 2025 — REGISTERED-PRINCIPAL REGISTER
- 25 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Mar 2025 — PUBLISHED FOR OPPOSITION
- 19 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Mar 2025 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 03 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Feb 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Feb 2025 — NON-FINAL ACTION E-MAILED
- 11 Feb 2025 — NON-FINAL ACTION WRITTEN
- 03 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE